Skip to main content
Equibles

WELLINGTON MANAGEMENT GROUP LLP

Position in EOLS — Evolus, Inc.

CIK 902219 Boston, MA
Back to EOLS Full portfolio

Position in EOLS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,179,341
-$118,471 QoQ
Shares Held
169,934
-12.9% QoQ
Ownership
0.257%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 158 holders
Holding Since
Dec 2023
10 quarters on record
Voting authority Sole 0% Shared 69% None 31%

Common Shares in EOLS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

WELLINGTON MANAGEMENT GROUP LLP holds $2,155,261,599 across 33 Drug Manufacturers - Specialty & Generic names. EOLS ranks #27 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 UTHR
UNITED THERAPEUTICS Corp
 1,379,025 $747,197,111
2 ZTS
Zoetis Inc.
 9,423,895 $677,201,094
3 TEVA
Teva Pharmaceutical Industries Ltd
 7,671,157 $259,898,795
4 ALKS
Alkermes plc.
 2,814,804 $147,495,727
5 LNTH
Lantheus Holdings, Inc.
 1,013,063 $112,389,207
6 ELAN
Elanco Animal Health Inc
 2,676,050 $65,857,589
7 HLN
Haleon plc
 3,273,583 $30,542,527
8 XERS
Xeris Biopharma Holdings, Inc.
 2,365,103 $18,731,613

All Filings in EOLS

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,179,341 169,934
2025-12-31 $1,297,812 195,160
2025-09-30 $1,131,662 184,310
2025-06-30 $1,510,624 164,020
2025-03-31 $1,810,117 150,467
2024-12-31 $1,791,118 162,239
2024-09-30 $2,835,631 175,039
2024-06-30 $1,457,415 134,324
2024-03-31 $1,752,688 125,192
2023-12-31 $684,702 65,024